Title 42 — The Public Health and WelfareRelease 119-73

§244c Cardiomyopathy research

Title 42 › Chapter CHAPTER 6A— - PUBLIC HEALTH SERVICE › Subchapter SUBCHAPTER II— - GENERAL POWERS AND DUTIES › Part Part B— - Federal-State Cooperation › § 244c

Last updated Apr 6, 2026|Official source

Summary

The Secretary, with input from the Director of the National Institutes of Health, may expand and coordinate NIH research on cardiomyopathy. That work can include studying causes (like genetic factors and molecular markers), long‑term health outcomes for all age groups, and long-term or retrospective studies to find effective treatments and outcomes. The Secretary must make sure this research does not duplicate work done by other HHS agencies. Not later than 18 months after December 23, 2024, the Secretary, with the NIH Director, must send Congress a report that outlines current NIH research on cardiomyopathy and that identifies a research agenda for adult forms, plans for pediatric research, and the areas of greatest need. The term “cardiomyopathy” has the meaning given in section 244a.

Full Legal Text

Title 42, §244c

The Public Health and Welfare — Source: USLM XML via OLRC

(a)The Secretary, in consultation with the Director of the National Institutes of Health, may expand and coordinate research and related activities of the National Institutes of Health with respect to cardiomyopathy, which may include research with respect to—

(1)causation of cardiomyopathy, including genetic causes and molecular biomarkers;

(2)long-term health outcomes in individuals with cardiomyopathy, including infants, children, teenagers, adults, and elderly individuals; and

(3)studies using longitudinal data and retrospective analysis to identify effective treatments and outcomes for individuals with cardiomyopathy.

(b)The Secretary shall ensure that any research and activities related to cardiomyopathy under this section do not unnecessarily duplicate activities, programs, or efforts of other agencies and offices within the Department of Health and Human Services.

(c)Not later than 18 months after December 23, 2024, the Secretary, in consultation with the Director of the National Institutes of Health, shall submit to Congress a report—

(1)outlining the ongoing research efforts of the National Institutes of Health regarding cardiomyopathy; and

(2)identifying—

(A)a research agenda regarding adult forms of cardiomyopathy;

(B)plans for researching cardiomyopathy affecting the pediatric population; and

(C)the areas of greatest need for such research.

(d)In this section, the term “cardiomyopathy” has the meaning given to such term in section 244a of this title.

Reference

Citations & Metadata

Citation

42 U.S.C. § 244c

Title 42 — The Public Health and Welfare

Last Updated

Apr 6, 2026

Release point: 119-73